Valion Bio Inc.
VBIO | NASDAQ
$0.53
-$0.02 (-3.64%)
At close: Nov 2, 2026, 4:00 PM ET
$0.55
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 9:21 AM ET
Fiscal Year Period Ending | FY 2026 Dec 31, 2025 | FY 2025 Dec 31, 2024 | FY 2024 Dec 31, 2023 | FY 2023 Dec 31, 2022 | FY 2022 Dec 31, 2021 | FY 2021 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.62 | -7.48 | -4.33 | -15.38 | -39.89 | -330.36 |
PEG Ratio | 0.08 | 0.08 | 0.05 | 0.27 | -0.08 | 26.92 |
PS Ratio | n/a | n/a | 30.35 | 84.09 | 269.45 | 1.4K |
PB Ratio | 2.49 | 16.68 | 9.97 | 42.62 | 25.52 | -1.02K |
P/FCF Ratio | -5.95 | -7.39 | -4.14 | -17.33 | -60.35 | -397.14 |
P/OCF Ratio | -5.98 | -7.39 | -4.19 | -17.35 | -60.35 | -397.14 |
OCF/S Ratio | n/a | n/a | -723.72 | -484.73 | -446.46 | -351.98 |
Debt / Equity Ratio | 0.38 | n/a | 0.10 | 0.15 | 0.05 | -1.25 |
Quick Ratio | 20.13 | 8.53 | 2.78 | 2.37 | 11.37 | 0.99 |
Current Ratio | 20.13 | 9.70 | 3.32 | 2.83 | 11.72 | 1.17 |
Asset Turnover | n/a | n/a | 0.23 | 0.31 | 0.08 | 0.56 |
Interest Coverage | -54.10 | n/a | n/a | n/a | -3.09 | -7.85 |
Return on Equity | -52.85% | -223.08% | -230.28% | -278.13% | -64% | 309.18% |
Return on Assets | -28.09% | -201.46% | -159.86% | -171.85% | -56.49% | -237.69% |
Return on Invested Capital | -25.51% | -174.20% | -208.79% | -242.74% | -40.29% | -1.14K% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 24.40% | 16.25% | -3.66% | -27.09% |
Net Profit Margin | n/a | n/a | -701.02% | -548.70% | -675.74% | -423.14% |
Pretax Profit Margin | n/a | n/a | -701.02% | -548.70% | -675.74% | -423.14% |
Operating Profit Margin | n/a | n/a | -701.11% | -548.80% | -448.13% | -386.16% |
FCF Margin | n/a | n/a | -733.76% | -485.33% | -446.46% | -351.98% |
EBITDA Margin | n/a | n/a | -685.63% | -539.35% | -446.22% | -385.23% |
Add to Watchlist
Select watchlists to add or remove VBIO